Bio-Techne (TECH) Deferred Taxes (2009 - 2026)
Bio-Techne (TECH) posted quarterly Deferred Taxes of $2.8 million for Q1 2026, up 152.55% year-over-year from $1.1 million in Q1 2025, and up 4047.22% quarter-over-quarter from -$72000.0 in Q4 2025.
Analysis
Bio-Techne (TECH) Deferred Taxes (2009 - 2026) Analysis & Trends
Bio-Techne's Deferred Taxes history runs 18 years deep, the most recent figure standing at $2.8 million for Q1 2026.
- In Q1 2026, Deferred Taxes rose 152.55% year-over-year to $2.8 million; the TTM figure through Mar 2026 stood at -$24.2 million (up 14.59% YoY), while the FY2025 annual figure was -$51.1 million, down 29.56% from the prior year.
- Deferred Taxes for Q1 2026 stood at $2.8 million, up from -$72000.0 in the prior quarter.
- The five-year high for Deferred Taxes was $5.3 million in Q3 2025, with the low at -$32.3 million in Q2 2025.
- The 5-year median for Deferred Taxes is -$5.4 million (2025), against an average of -$6.6 million.
- The sharpest annual moves came in 2023 and 2025: Deferred Taxes slumped 2586.41% in 2023, then surged 198.78% in 2025.
- Bio-Techne's Deferred Taxes stood at -$1.6 million in 2022, then tumbled by 571.03% to -$10.7 million in 2023, then gained by 24.68% to -$8.1 million in 2024, then surged by 99.11% to -$72000.0 in 2025, then surged by 4047.22% to $2.8 million in 2026.
- Business Quant data shows TECH's Deferred Taxes at $2.8 million in Q1 2026, -$72000.0 in Q4 2025, and $5.3 million in Q3 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Deferred Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | -69.70 Mn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | 194.40 Mn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | - |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | - |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | 2.66 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | - |
| 10 | Bio-Techne | 11.29 Bn | 11.03 Bn | 211.39 Mn | 5.15 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 5.15 Mn |
| Mar 31, 2026 | 2.84 Mn |
| Dec 31, 2025 | -72,000.00 |
| Sep 30, 2025 | 5.28 Mn |
| Jun 30, 2025 | -32.28 Mn |
| Mar 31, 2025 | -5.41 Mn |
| Dec 31, 2024 | -8.08 Mn |
| Sep 30, 2024 | -5.34 Mn |
| Jun 30, 2024 | -9.55 Mn |
| Mar 31, 2024 | -7.58 Mn |
| Dec 31, 2023 | -10.72 Mn |
| Sep 30, 2023 | -11.59 Mn |
| Jun 30, 2023 | -6.92 Mn |
| Mar 31, 2023 | -16.29 Mn |
| Dec 31, 2022 | -1.60 Mn |
| Sep 30, 2022 | -4.77 Mn |
| Jun 30, 2022 | -1.07 Mn |
| Mar 31, 2022 | 655,000.00 |
| Dec 31, 2021 | 1.83 Mn |
| Sep 30, 2021 | 5.41 Mn |